Andrew Combs's Net Worth

$1.39 Million

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Andrew Combs?

Andrew Combs has an estimated net worth of $1.39 Million. This is based on reported shares in Prelude Therapeutics Inc.

SEC CIK

Andrew Combs's CIK is 0001825005

Past Insider Trading and Trends

2021 was Andrew Combs's most active year for acquiring shares with 3 total transactions. Andrew Combs's most active month to acquire stocks was the month of January. 2022 was Andrew Combs's most active year for disposing of shares, totalling 1 transactions. Andrew Combs's most active month to dispose stocks was the month of March. 2022 saw Andrew Combs paying a total of $68,157.18 for 136,062 shares, this is the most they've acquired in one year. In 2022 Andrew Combs cashed out on 36,062 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18

Chief Chemistry Officer

Andrew Combs owns 304,442 units of Common Stock which is worth $1,577,009.56. From 2020 to 2024 Andrew Combs acquired a total of 45,062 shares in Prelude Therapeutics Inc at a cost of $182,037.18.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 7
Form 4
+13.44%
36.06K
$1.89
$68,157.18
304.44K
Mar 31 - Apr 1
Form 4
—
0
—
—
0
Feb 15
Form 4
+3.07%
8K
$11.86
$94,880.00
268.38K
Dec 13 - Dec 14
Form 4
—
0
—
—
0
Jul 20
Form 4
+0.39%
1K
$19.00
$19,000.00
260.38K
Sep 29
Form 3
—
0
—
—
0
No matching records found